ATE178906T1 - Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen - Google Patents

Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen

Info

Publication number
ATE178906T1
ATE178906T1 AT95944704T AT95944704T ATE178906T1 AT E178906 T1 ATE178906 T1 AT E178906T1 AT 95944704 T AT95944704 T AT 95944704T AT 95944704 T AT95944704 T AT 95944704T AT E178906 T1 ATE178906 T1 AT E178906T1
Authority
AT
Austria
Prior art keywords
rsv
respiratory syncytial
protein
syncytial virus
subtypes
Prior art date
Application number
AT95944704T
Other languages
English (en)
Inventor
Johannes Petrus Mari Langedijk
Diergezondheid
Original Assignee
Stichting Inst Dierhouderij
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Inst Dierhouderij filed Critical Stichting Inst Dierhouderij
Application granted granted Critical
Publication of ATE178906T1 publication Critical patent/ATE178906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95944704T 1994-08-25 1995-08-22 Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen ATE178906T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94202440 1994-08-25

Publications (1)

Publication Number Publication Date
ATE178906T1 true ATE178906T1 (de) 1999-04-15

Family

ID=8217137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95944704T ATE178906T1 (de) 1994-08-25 1995-08-22 Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen

Country Status (10)

Country Link
US (1) US6077511A (de)
EP (1) EP0777685B1 (de)
JP (1) JPH10512846A (de)
AT (1) ATE178906T1 (de)
AU (1) AU710713B2 (de)
CA (1) CA2198279A1 (de)
DE (1) DE69509103T2 (de)
NO (1) NO970829L (de)
NZ (1) NZ291243A (de)
WO (1) WO1996006112A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO026596A0 (en) * 1996-06-05 1996-06-27 Biomolecular Research Institute Limited Viral peptide
FR2766192B1 (fr) * 1997-07-17 2001-07-13 Pf Medicament Epitopes du vrs et anticorps les comportant, utiles dans le diagnostic et la therapie
AU2002210384B2 (en) * 2000-10-17 2006-10-19 Besst-Test Aps Assay for directly detecting a RS virus related biological cell in a body fluid sample
ATE412666T1 (de) 2000-10-18 2008-11-15 Us Gov Health & Human Serv Zusammensetzungen und verfahren zur modulierung von rsv-infektionen und -immunität
US6605283B1 (en) 2002-11-01 2003-08-12 The United States Of America As Represented By The Secretary Of Agriculture Nucleotide sequence for the Avian Metapneumovirus (Colorado) attachment glycoprotein gene
EA200501285A1 (ru) * 2003-02-11 2006-02-24 Неофарм, Инк. Способ получения липосомальных препаратов
AU2007222798A1 (en) * 2006-03-06 2007-09-13 Symphogen A/S Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections
CA2678628A1 (en) * 2007-03-06 2008-09-12 Symphogen A/S Recombinant antibodies for treatment of respiratory syncytial virus infections
CN102711818B (zh) * 2009-08-04 2014-09-24 美利坚合众国政府疾病控制和预防中心,健康和公共事业部 抗rsv免疫原和免疫方法
CN106008716B (zh) 2010-07-07 2019-08-13 人工细胞科技公司 呼吸道合胞病毒抗原组合物和方法
WO2014019718A1 (en) 2012-08-01 2014-02-06 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) respiratory syncytial virus (rsv) vaccine
CA3107037A1 (en) * 2018-08-08 2020-02-13 Trellis Bioscience, Llc Improved rsv passive and active vaccines
JP7657727B2 (ja) 2019-04-02 2025-04-07 サノフイ 抗原性多量体呼吸器合胞体ウイルスポリペプチド

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0540645A4 (en) * 1990-07-24 1993-12-29 The Uab Research Foundation Methods of use of bovine respiratory syncytial virus recombinant dna, proteins vaccines, antibodies, and transformed cells
FR2718452B1 (fr) * 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.

Also Published As

Publication number Publication date
EP0777685B1 (de) 1999-04-14
US6077511A (en) 2000-06-20
AU710713B2 (en) 1999-09-30
EP0777685A1 (de) 1997-06-11
CA2198279A1 (en) 1996-02-29
DE69509103T2 (de) 1999-09-30
NZ291243A (en) 1998-10-28
NO970829D0 (no) 1997-02-24
AU3231695A (en) 1996-03-14
NO970829L (no) 1997-04-18
WO1996006112A1 (en) 1996-02-29
DE69509103D1 (de) 1999-05-20
JPH10512846A (ja) 1998-12-08

Similar Documents

Publication Publication Date Title
ATE178906T1 (de) Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen
RU2220978C2 (ru) Пептид, индуцирующий образование антител, которые реагируют с двумя различными изолятами вррсс (варианты), иммуногенная композиция, вакцина для профилактики заражения репродуктивно-респираторным синдромом свиней, антитело, диагностический набор (варианты)
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
PT97159A (pt) Processo para a preparacao de uma proteina do antigenio de superficie da hepatite b ou de um seu fragmento e processo para a preparacao de uma vacina
SE8704185L (sv) Nya peptider, artificiella antigener och immunoanalystestsatser
Falsey et al. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults
Chomel et al. Rapid diagnosis of influenza infection of NP antigen using an immunocapture ELISA test
DK1018017T3 (da) Serum-antigen indfangningsimmunoassay for bovin-viral diarrévirus
ATE160358T1 (de) Detektion des immunschwäche-virus aus felis
HRP20220971T1 (hr) Metoda za imunološko doziranje specifičnih antitijela na virusne antigene poks virusa
KR910019641A (ko) 사람 유두종 바이러스(hpv) 18의 단백질상의 혈청 반응성 에피토프
Hammond et al. Sensitivity and specificity of enzyme immunoassay for serodiagnosis of influenza A virus infections
Rima et al. Correlation between humoral immune responses and presence of virus in the CNS in dogs experimentally infected with canine distemper virus
Ristow et al. Detection and characterization of rainbow trout antibody against infectious hematopoietic necrosis virus
BRPI0200986B8 (pt) método de determinação da presença de hcv em uma amostra
WO2021222237A1 (en) Detection of viruses in facemasks
DK589489A (da) Antistof af igm-isotypen og fragment deraf, deres anvendelse med prognose eller diagnose af aids og diagnosesaet dertil
NO913037D0 (no) Peptider med for alfal-mikroglobulin karakteristiske antigene determinanter.
KR940005666A (ko) C형 간염 바이러스를 분류하기 위한 항원성 펩티드 ,이 펩티드를 포함하는 키트 및 이 펩티드를 사용하여 c형 간염 바이러스를 분류하는 방법
Van der Logt et al. Hemadsorption immunosorbent technique for determination of mumps immunoglobulin M antibody
DK0623145T3 (da) Peptider af caseinomacropeptid, antistoffer mod disse peptider og anvendelser deraf
ATE138078T1 (de) Analysemethode für infektiöse pferdeanämie-viren (eia-virus)
RU93039551A (ru) Способ получения специфической сыворотки для лечения, диагностики и профилактики вирусной геморрагической болезни кроликов и набор для диагностики болезни
ATE426038T1 (de) Nachweis des rinderdiarrhoevirus in haarproben
Aymard et al. Determination of anti-neuraminidase antibody titres in human sera by inhibition of the agglutination of fetuin-latex by influenza viruses

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties